166 related articles for article (PubMed ID: 22025313)
1. Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.
Felix AS; Stone RA; Chivukula M; Bowser R; Parwani AV; Linkov F; Edwards RP; Weissfeld JL
Int J Cancer; 2012 Jul; 131(2):E114-21. PubMed ID: 22025313
[TBL] [Abstract][Full Text] [Related]
2. CXCL12, CXCR4 and CXCR7 expression in brain metastases.
Salmaggi A; Maderna E; Calatozzolo C; Gaviani P; Canazza A; Milanesi I; Silvani A; DiMeco F; Carbone A; Pollo B
Cancer Biol Ther; 2009 Sep; 8(17):1608-14. PubMed ID: 19625779
[TBL] [Abstract][Full Text] [Related]
3. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of stromal cell-derived factor-1 and CXCR4 in endometrial carcinoma tissues and cell lines].
Li XP; Zhao D; Gao M; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):458-62. PubMed ID: 17068613
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
[TBL] [Abstract][Full Text] [Related]
6. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
8. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
9. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.
Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z
Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915
[TBL] [Abstract][Full Text] [Related]
10. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells.
Kubarek Ł; Jagodzinski PP
FEBS Lett; 2007 Apr; 581(7):1441-8. PubMed ID: 17362937
[TBL] [Abstract][Full Text] [Related]
12. Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis.
Hall JM; Korach KS
Mol Carcinog; 2013 Sep; 52(9):715-25. PubMed ID: 22549810
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
Piqué DG; Greally JM; Mar JC
BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
[TBL] [Abstract][Full Text] [Related]
15. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
[TBL] [Abstract][Full Text] [Related]
16. CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.
de Oliveira KB; Guembarovski RL; Guembarovski AM; da Silva do Amaral Herrera AC; Sobrinho WJ; Ariza CB; Watanabe MA
Clin Exp Med; 2013 Aug; 13(3):211-9. PubMed ID: 22699677
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
18. Estrogen promotes the survival of human secretory phase endometrial stromal cells via CXCL12/CXCR4 up-regulation-mediated autophagy inhibition.
Mei J; Zhu XY; Jin LP; Duan ZL; Li DJ; Li MQ
Hum Reprod; 2015 Jul; 30(7):1677-89. PubMed ID: 25976655
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of chemokine CXCL12 and receptor CXCR4 in adenomyosis].
Wang S; Duan H; Li BH; Wang YY; Huang JH; Guo ZC
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):754-759. PubMed ID: 33228346
[No Abstract] [Full Text] [Related]
20. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
